SCHEMBL24313631

SCHEMBL24313631

CN(C)C(=O)c1ccc2cc(C(=O)N[S+]([O-])c3ccccc3-c3ccccc3)oc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.40
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
TP53 P04637 2/20 0.37
RXFP1 Q9HBX9 1/20 0.37
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37
ACKR3 P25106 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRK1 P41145 1/20 0.37
TMEM97 Q5BJF2 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314307 0.90 RAB9A (0.45) HDAC6NPC1RAB9ASMN1; SMN2TP53
SCHEMBL24313744 0.88 HDAC6 (0.40) HDAC6NPC1RAB9ASMN1; SMN2TP53
SCHEMBL26008098 0.86 SLC16A3 (0.42) NPC1RAB9ASMN1; SMN2TP53ACKR3
SCHEMBL24313789 0.85 NPC1 (0.43) NPC1RAB9ASMN1; SMN2TP53RXFP1
SCHEMBL22601061 0.84 CHRNA7 (0.40) HDAC6NPC1RAB9ASMN1; SMN2TP53
SCHEMBL22601047 0.84 ACKR3 (0.37) NPC1RAB9ASMN1; SMN2TP53ACKR3
SCHEMBL22601033 0.84 NPC1 (0.51) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL22601146 0.84 NPC1 (0.39) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL22600839 0.83 RAB9A (0.41) HDAC6NPC1RAB9ASMN1; SMN2TP53
SCHEMBL24313793 0.83 ALDH1A1 (0.42) HDAC6NPC1RAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed